BIOLASE INC (BIOL)
US0909117022 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -20.63M | -28.63M | -16.16M | -16.83M | -17.86M | |||
| Depreciation Amortization | 2.80M | 500.00K | 400.00K | 500.00K | 980.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 10.00K | |||
| Change In Working Capital | 1.02M | -5.07M | -1.94M | 1.75M | -1.11M | |||
| Interest Paid | 1.92M | 1.52M | 1.77M | 1.88M | 1.78M | |||
| Taxes Paid | 41.00K | 60.00K | 170.00K | 20.00K | 40.00K | |||
| Other non cash items | 2.72M | 6.45M | 990.00K | 1.78M | 5.23M | |||
| OPERATING CASH FLOW | -14.09M | -26.76M | -16.71M | -12.80M | -12.75M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.31M | -3.73M | -710.00K | -100.00K | -210.00K | |||
| Other Investing Activity | 182.00K | N/A | N/A | N/A | 0.00 | |||
| INVESTING CASH FLOW | -1.13M | -3.73M | -710.00K | -100.00K | -210.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -165.00K | -1.00M | -30.00K | 2.44M | 2.50M | |||
| Stock Issued/Repurchased | 17.60M | 5.60M | 31.11M | 24.96M | 9.18M | |||
| Other Financing Activity | 0.00 | 0.00 | -1.14M | -3.05M | -950.00K | |||
| FINANCING CASH FLOW | 17.43M | 4.60M | 29.95M | 24.35M | 10.72M | |||
| Exchange Rate Effect | 171.00K | -110.00K | -240.00K | 320.00K | -20.00K | |||
| CHANGE IN CASH | 2.39M | -26.00M | 12.29M | 11.77M | -2.26M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -14.09M | -26.76M | -16.71M | -12.80M | -12.75M | |||
| Capital Expenditure | -1.31M | -3.73M | -710.00K | -100.00K | -210.00K | |||
| FREE CASH FLOW | -15.40M | -30.49M | -17.42M | -12.90M | -12.96M | |||
All data in USD